,reactionoutcome,reactionmeddraversionpt,reactionmeddrapt,safetyreportid
0,6,22.0,Arthralgia,16552045
1,6,22.0,Joint stiffness,16552045
0,3,22.1,Hyperbilirubinaemia,16552054
1,3,22.1,Anaemia,16552054
0,6,22.0,Visual impairment,16552116
1,6,22.0,Headache,16552116
2,6,22.0,Encephalopathy,16552116
3,6,22.0,Memory impairment,16552116
4,6,22.0,Confusional state,16552116
0,6,22.0,Renal failure,16552160
1,6,22.0,Drug intolerance,16552160
2,6,22.0,Product dose omission,16552160
3,6,22.0,Hospitalisation,16552160
4,6,22.0,Product use in unapproved indication,16552160
5,1,22.0,Vomiting,16552160
6,6,22.0,Nausea,16552160
0,1,22.0,Pulmonary embolism,16552169
1,1,22.0,Tumour thrombosis,16552169
2,1,22.0,Deep vein thrombosis,16552169
0,6,22.0,Interstitial lung disease,16552171
0,6,22.1,Impaired self-care,16552175
1,6,22.1,Hallucination,16552175
2,3,22.1,Arthritis,16552175
3,2,22.1,Diabetic foot,16552175
4,3,22.1,Muscle spasms,16552175
5,3,22.1,Diarrhoea,16552175
6,6,22.1,Skin ulcer,16552175
7,6,22.1,Malaise,16552175
8,2,22.1,Diabetic foot infection,16552175
9,6,22.1,Confusional state,16552175
0,6,22.0,Pulmonary toxicity,16552177
0,3,22.0,Diarrhoea,16552178
1,3,22.0,Dehydration,16552178
2,3,22.0,Decreased appetite,16552178
0,1,22.1,Diarrhoea,16552206
0,6,22.1,Therapeutic product effect incomplete,16552207
0,3,22.1,Arthralgia,16552220
1,1,22.1,Product dose omission,16552220
2,3,22.1,Back pain,16552220
3,3,22.1,Fatigue,16552220
4,3,22.1,Neck pain,16552220
0,6,22.0,Loss of personal independence in daily activities,16552244
0,3,22.0,Therapeutic product effect incomplete,16552312
1,,22.0,Hormone-refractory prostate cancer,16552312
0,6,22.0,Rash generalised,16552523
1,6,22.0,Product dose omission,16552523
0,6,22.0,Intentional dose omission,16552542
1,6,22.0,Lethargy,16552542
2,1,22.0,Full blood count decreased,16552542
3,6,22.0,Body height decreased,16552542
0,6,22.0,Neoplasm progression,16552544
1,6,22.0,Full blood count decreased,16552544
0,6,22.1,Pain in extremity,16552569
1,6,22.1,Blood creatinine increased,16552569
2,2,22.1,Tendon disorder,16552569
3,6,22.1,Fatigue,16552569
4,6,22.1,Myalgia,16552569
5,6,22.1,Arthralgia,16552569
0,6,22.0,Abdominal pain,16552570
1,6,22.0,Hypertension,16552570
2,6,22.0,Fatigue,16552570
3,6,22.0,Dysphonia,16552570
4,6,22.0,Eructation,16552570
0,6,22.1,Malaise,16552587
0,3,22.1,Malaise,16552613
0,6,22.0,Fatigue,16552619
1,6,22.0,Diabetes mellitus,16552619
2,6,22.0,Corrective lens user,16552619
3,6,22.0,Hypertension,16552619
0,6,22.0,Red blood cell count decreased,16552626
1,6,22.0,White blood cell count decreased,16552626
2,6,22.0,Fatigue,16552626
0,2,22.0,Cholestasis,16552639
1,2,22.0,Acute kidney injury,16552639
0,1,22.1,Overdose,16552734
1,2,22.1,Delirium,16552734
2,5,22.1,Malignant neoplasm progression,16552734
0,6,22.0,Disease progression,16552736
1,6,22.0,Metastasis,16552736
2,6,22.0,Oestrogen receptor positive breast cancer,16552736
0,6,22.0,Rash,16552779
1,6,22.0,Condition aggravated,16552779
0,6,22.0,Urinary tract infection,16552799
1,6,22.0,Dysuria,16552799
2,6,22.0,Micturition urgency,16552799
3,3,22.0,Peripheral swelling,16552799
4,6,22.0,Renal pain,16552799
5,6,22.0,Urine output increased,16552799
6,6,22.0,Hypoacusis,16552799
7,1,22.0,Nausea,16552799
8,1,22.0,Headache,16552799
9,6,22.0,Haematuria,16552799
10,6,22.0,Weight decreased,16552799
11,1,22.0,Dehydration,16552799
12,1,22.0,Chills,16552799
13,1,22.0,Pyrexia,16552799
14,6,22.0,Incontinence,16552799
15,6,22.0,Pollakiuria,16552799
16,6,22.0,Body height decreased,16552799
0,6,22.0,Neoplasm progression,16552804
0,6,22.1,Erythema,16552806
1,6,22.1,Infection,16552806
2,6,22.1,Ill-defined disorder,16552806
3,6,22.1,Cough,16552806
4,6,22.1,Pain in extremity,16552806
5,6,22.1,Tongue discolouration,16552806
6,6,22.1,Sensitive skin,16552806
7,6,22.1,Weight increased,16552806
8,6,22.1,Vomiting,16552806
9,6,22.1,Dry mouth,16552806
10,6,22.1,Dysgeusia,16552806
11,6,22.1,Insomnia,16552806
12,6,22.1,Peripheral swelling,16552806
0,6,22.0,Full blood count decreased,16553033
0,6,22.0,Therapeutic product effect incomplete,16553144
1,6,22.0,Breast cancer,16553144
0,6,22.0,Bone pain,16553198
1,6,22.0,Disease progression,16553198
0,6,22.0,Treatment failure,16553209
1,6,22.0,Disease progression,16553209
0,6,22.0,Breast cancer metastatic,16553210
0,1,22.1,Nausea,16553250
1,2,22.1,Seizure,16553250
2,6,22.1,Decreased appetite,16553250
3,5,22.1,Acute respiratory distress syndrome,16553250
4,2,22.1,Constipation,16553250
5,5,22.1,Sudden death,16553250
0,6,22.0,Breast cancer,16553273
1,6,22.0,Breast cancer metastatic,16553273
2,6,22.0,Malignant neoplasm progression,16553273
3,6,22.0,Metastases to bone,16553273
4,6,22.0,Drug ineffective,16553273
0,6,22.0,Drug resistance,16553299
0,1,22.0,Back pain,16553312
1,1,22.0,Dyspnoea,16553312
2,1,22.0,Asthenia,16553312
3,1,22.0,Contusion,16553312
0,6,22.1,Bronchial haemorrhage,16553361
1,1,22.1,Epistaxis,16553361
0,,22.0,Renal impairment,16553373
1,,22.0,Dialysis,16553373
0,3,22.0,Colitis,16553437
1,3,22.0,Proctitis,16553437
0,6,22.0,Off label use,16553866
1,1,22.0,Gastrointestinal perforation,16553866
2,2,22.0,Peritonitis,16553866
0,1,22.0,Febrile neutropenia,16553960
1,1,22.0,Gastroenteritis,16553960
2,1,22.0,Septic shock,16553960
0,5,22.1,Sepsis,16553974
1,1,22.1,Stomatitis,16553974
0,1,22.1,Decreased appetite,16553980
1,1,22.1,Neutrophil count decreased,16553980
2,1,22.1,Platelet count decreased,16553980
3,1,22.1,Weight decreased,16553980
0,1,22.1,Gingival bleeding,16554005
1,1,22.1,Condition aggravated,16554005
2,1,22.1,Urinary tract infection,16554005
3,3,22.1,Headache,16554005
4,6,22.1,Condition aggravated,16554005
5,3,22.1,Depressed mood,16554005
6,4,22.1,Abdominal pain upper,16554005
7,3,22.1,Pain,16554005
8,3,22.1,Insomnia,16554005
9,1,22.1,Alanine aminotransferase increased,16554005
10,6,22.1,Nasopharyngitis,16554005
11,3,22.1,Hypoaesthesia,16554005
12,1,22.1,Abdominal pain,16554005
13,3,22.1,Nausea,16554005
14,1,22.1,Gastroenteritis viral,16554005
15,1,22.1,Vomiting,16554005
16,3,22.1,Fatigue,16554005
17,3,22.1,Anxiety,16554005
18,3,22.1,Dizziness,16554005
19,6,22.1,Constipation,16554005
20,3,22.1,Gastrointestinal disorder,16554005
21,1,22.1,Lower respiratory tract infection,16554005
22,1,22.1,Anaemia,16554005
23,1,22.1,Rhinorrhoea,16554005
24,1,22.1,Viral infection,16554005
25,1,22.1,Peripheral swelling,16554005
26,4,22.1,Back pain,16554005
27,1,22.1,Mucosal inflammation,16554005
28,1,22.1,Diarrhoea,16554005
0,6,22.0,No adverse event,16554033
1,6,22.0,Product dose omission,16554033
0,6,22.0,Malignant neoplasm progression,16554124
1,6,22.0,Drug resistance,16554124
0,6,22.0,Abdominal distension,16554624
1,6,22.0,Ascites,16554624
0,6,22.0,Lung neoplasm malignant,16554631
0,3,22.0,Nausea,16554733
1,6,22.0,Weight decreased,16554733
2,3,22.0,Vomiting,16554733
0,6,22.0,Ovarian cancer recurrent,16554745
0,6,22.0,Neutrophil count decreased,16554757
0,6,22.0,Product dose omission,16554761
1,6,22.0,Liver disorder,16554761
2,6,22.0,Bone pain,16554761
0,6,22.0,Off label use,16554762
1,6,22.0,Product use in unapproved indication,16554762
2,6,22.0,Weight decreased,16554762
0,6,22.0,Oral pain,16554765
0,6,22.0,Haemorrhage urinary tract,16554779
1,6,22.0,Anuria,16554779
0,2,22.0,Adrenal disorder,16554809
1,1,22.0,Bursitis,16554809
0,1,22.0,Embolism,16554825
1,6,22.0,Phlebitis,16554825
2,6,22.0,Pulmonary embolism,16554825
0,6,22.0,Metastases to liver,16554889
1,6,22.0,Malignant neoplasm progression,16554889
0,1,22.1,Leukopenia,16554891
1,6,22.1,Second primary malignancy,16554891
2,6,22.1,Thyroid cancer,16554891
3,6,22.1,Pleural effusion,16554891
4,6,22.1,Fatigue,16554891
5,2,22.1,Neoplasm progression,16554891
6,6,22.1,Alopecia,16554891
7,3,22.1,Bone marrow failure,16554891
8,1,22.1,Neutropenia,16554891
0,4,22.0,Dizziness,16554896
1,4,22.0,Paraesthesia,16554896
2,4,22.0,Sensation of foreign body,16554896
3,4,22.0,Dyspnoea,16554896
0,6,22.1,Leukopenia,16554949
1,2,22.1,Taste disorder,16554949
2,6,22.1,Diarrhoea,16554949
3,1,22.1,Bone marrow failure,16554949
4,3,22.1,Fatigue,16554949
5,2,22.1,Nausea,16554949
0,1,22.0,Gamma-glutamyltransferase increased,16554953
0,6,22.0,Ill-defined disorder,16554961
1,1,22.0,Hypertension,16554961
0,1,22.0,Anal abscess,16555278
1,6,22.0,Colitis,16555278
0,1,22.0,Stomatitis,16555280
0,2,22.1,Neck pain,16555321
1,3,22.1,Aphonia,16555321
2,3,22.1,Blood count abnormal,16555321
3,3,22.1,Hypophagia,16555321
4,1,22.1,Sneezing,16555321
5,3,22.1,Rhinorrhoea,16555321
6,6,22.1,Oropharyngeal pain,16555321
7,2,22.1,Diarrhoea,16555321
8,6,22.1,Pain in extremity,16555321
9,3,22.1,Fatigue,16555321
10,1,22.1,Peripheral swelling,16555321
11,2,22.1,Back pain,16555321
12,3,22.1,Ageusia,16555321
13,3,22.1,Weight decreased,16555321
14,3,22.1,Abdominal pain upper,16555321
15,1,22.1,Sinus pain,16555321
16,1,22.1,Decreased appetite,16555321
17,1,22.1,Asthenia,16555321
18,6,22.1,Blister,16555321
19,3,22.1,Myalgia,16555321
20,3,22.1,Hypertension,16555321
21,2,22.1,Dysgeusia,16555321
22,1,22.1,Headache,16555321
23,3,22.1,Pain,16555321
24,3,22.1,Nervousness,16555321
25,6,22.1,Gastric disorder,16555321
26,3,22.1,Somnolence,16555321
27,1,22.1,Pollakiuria,16555321
28,3,22.1,Anxiety,16555321
0,5,22.0,Pneumonia staphylococcal,16555327
0,5,22.1,Respiratory failure,16555333
1,5,22.1,Malignant neoplasm progression,16555333
2,5,22.1,Radiation pneumonitis,16555333
0,6,22.0,Malaise,16555363
1,6,22.0,Hypotension,16555363
2,6,22.0,Extrasystoles,16555363
3,6,22.0,Infusion related reaction,16555363
0,1,22.0,Neutropenia,16555416
1,1,22.0,Thrombocytopenia,16555416
0,1,22.0,Thrombocytopenia,16555426
1,1,22.0,Neutropenia,16555426
0,1,22.1,Hyponatraemia,16555432
0,6,22.1,Malaise,16555476
1,6,22.1,Myocardial infarction,16555476
0,6,22.0,Prostate cancer,16555503
1,6,22.0,Haemoglobin decreased,16555503
2,6,22.0,Cutaneous calcification,16555503
3,6,22.0,Formication,16555503
4,6,22.0,General physical health deterioration,16555503
5,6,22.0,Musculoskeletal stiffness,16555503
6,6,22.0,Dyspepsia,16555503
7,6,22.0,Asthenia,16555503
8,6,22.0,Hydroureter,16555503
9,6,22.0,Hydronephrosis,16555503
0,1,22.0,General physical health deterioration,16555504
0,1,22.0,Pulmonary embolism,16555509
0,2,22.0,Upper limb fracture,16555516
0,6,22.0,Pulmonary tumour thrombotic microangiopathy,16555517
0,6,22.0,Hypoacusis,16555575
0,6,22.0,Arthralgia,16555602
1,6,22.0,Cerebral infarction,16555602
0,5,22.0,Death,16555670
0,5,22.0,Death,16555677
0,6,22.0,Dysphagia,16555729
1,6,22.0,Mucosal inflammation,16555729
0,4,22.0,Diarrhoea,16555772
0,6,22.0,Adverse drug reaction,16555791
1,6,22.0,Atrial fibrillation,16555791
2,6,22.0,Arrhythmia,16555791
3,6,22.0,Diabetes mellitus,16555791
4,6,22.0,Fluid retention,16555791
5,6,22.0,Hypertension,16555791
6,6,22.0,Cardiac failure congestive,16555791
7,6,22.0,Obesity,16555791
0,6,22.0,Metastases to bone,16555815
1,6,22.0,Metastases to central nervous system,16555815
2,1,22.0,Swelling,16555815
3,6,22.0,Pain,16555815
4,6,22.0,Cough,16555815
5,6,22.0,Musculoskeletal chest pain,16555815
6,6,22.0,Joint swelling,16555815
7,2,22.0,Pyrexia,16555815
8,6,22.0,Bone pain,16555815
9,6,22.0,Arthralgia,16555815
10,6,22.0,Arthropathy,16555815
11,3,22.0,Alopecia,16555815
12,6,22.0,Immune system disorder,16555815
13,6,22.0,Peripheral swelling,16555815
14,6,22.0,Metastases to spine,16555815
15,6,22.0,Joint injury,16555815
16,2,22.0,Pneumonia,16555815
17,6,22.0,Hypersensitivity,16555815
18,6,22.0,Swelling,16555815
19,6,22.0,Arthritis,16555815
20,6,22.0,Influenza,16555815
21,1,22.0,Migraine,16555815
22,6,22.0,Patellofemoral pain syndrome,16555815
23,6,22.0,Fatigue,16555815
24,6,22.0,Gait disturbance,16555815
25,6,22.0,Rhinorrhoea,16555815
26,6,22.0,Malaise,16555815
0,1,22.0,Throat tightness,16555823
1,1,22.0,Paraesthesia,16555823
2,1,22.0,Lividity,16555823
0,6,22.0,Drug intolerance,16555828
1,6,22.0,Hallucination,16555828
0,5,22.1,Haemorrhagic stroke,16555872
0,6,22.0,Acquired gene mutation,16555889
1,6,22.0,Drug resistance,16555889
2,6,22.0,Malignant neoplasm progression,16555889
0,1,22.0,Abdominal pain,16555893
1,1,22.0,Injection site pain,16555893
2,1,22.0,Circulatory collapse,16555893
0,1,22.0,Rash,16555901
1,1,22.0,Rib fracture,16555901
2,1,22.0,Lower respiratory tract infection,16555901
3,1,22.0,Appendicitis,16555901
4,3,22.0,Musculoskeletal chest pain,16555901
5,1,22.0,Febrile neutropenia,16555901
6,2,22.0,Neuropathy peripheral,16555901
7,3,22.0,Mouth ulceration,16555901
8,1,22.0,Urinary tract infection,16555901
0,2,22.0,Lung carcinoma cell type unspecified stage IV,16555909
1,6,22.0,Second primary malignancy,16555909
0,1,22.1,Sepsis,16555919
0,6,22.0,Interstitial lung disease,16555930
1,6,22.0,Immune-mediated adverse reaction,16555930
2,1,22.0,Therapy partial responder,16555930
0,1,22.0,Herpes zoster,16555931
0,4,22.0,Neutropenia,16555934
0,1,22.0,Dyspnoea,16555977
1,1,22.0,Vascular device infection,16555977
2,1,22.0,Vascular device infection,16555977
3,1,22.0,Neuropathy peripheral,16555977
4,1,22.0,Neurodermatitis,16555977
5,1,22.0,Diarrhoea,16555977
6,1,22.0,Fatigue,16555977
0,6,22.0,Non-small cell lung cancer metastatic,16556002
1,6,22.0,Metastases to liver,16556002
2,6,22.0,Colon cancer metastatic,16556002
3,6,22.0,Malignant neoplasm progression,16556002
4,6,22.0,Hand-foot-genital syndrome,16556002
5,6,22.0,Metastases to adrenals,16556002
6,6,22.0,Nausea,16556002
7,6,22.0,Diarrhoea,16556002
0,6,22.0,Asthenia,16556145
1,5,22.0,Malignant neoplasm progression,16556145
2,6,22.0,Faeces soft,16556145
0,4,22.1,Female genital tract fistula,16556157
0,6,22.1,Fall,16556205
1,6,22.1,Hypotension,16556205
2,6,22.1,Asthenia,16556205
3,5,22.1,Death,16556205
4,6,22.1,Chronic obstructive pulmonary disease,16556205
5,6,22.1,Pleural effusion,16556205
6,6,22.1,Neutropenia,16556205
7,6,22.1,Dyspnoea,16556205
8,6,22.1,Cognitive disorder,16556205
9,6,22.1,Loss of consciousness,16556205
10,6,22.1,Malaise,16556205
11,6,22.1,Pneumonia,16556205
0,1,22.1,Syncope,16556221
0,6,22.0,Product administered to patient of inappropriate age,16556223
1,6,22.0,Off label use,16556223
0,6,22.1,Blood potassium decreased,16556225
1,6,22.1,Oropharyngeal pain,16556225
2,6,22.1,Blood count abnormal,16556225
3,6,22.1,Peripheral swelling,16556225
4,3,22.1,Feeling abnormal,16556225
5,6,22.1,Fatigue,16556225
0,1,22.1,Enterocolitis,16556285
0,2,22.0,Dyspnoea,16556287
1,6,22.0,Lymphangiosis carcinomatosa,16556287
2,6,22.0,Pleural effusion,16556287
0,3,22.1,Pericardial effusion,16556305
0,3,22.0,Pneumonia,16556308
0,5,22.1,Diffuse large B-cell lymphoma,16556356
1,3,22.1,Brachial plexopathy,16556356
2,1,22.1,Neurotoxicity,16556356
3,6,22.1,Pneumothorax,16556356
4,1,22.1,Neurotoxicity,16556356
5,1,22.1,Cytokine release syndrome,16556356
0,6,22.0,Neutropenia,16556370
1,6,22.0,Bone pain,16556370
0,5,22.0,Brain herniation,16556493
1,6,22.0,Hypertension,16556493
2,5,22.0,Putamen haemorrhage,16556493
3,6,22.0,Proteinuria,16556493
0,5,22.0,Death,16556533
0,3,22.0,Neutropenia,16556646
1,6,22.0,Malignant neoplasm progression,16556646
2,6,22.0,Pleural effusion,16556646
3,6,22.0,Fatigue,16556646
4,6,22.0,Musculoskeletal pain,16556646
5,1,22.0,Anaemia,16556646
6,6,22.0,Metastases to lymph nodes,16556646
7,6,22.0,Metastases to lung,16556646
8,6,22.0,Blood alkaline phosphatase increased,16556646
9,6,22.0,Blood lactate dehydrogenase increased,16556646
10,6,22.0,Inappropriate schedule of product administration,16556646
11,6,22.0,Breast cancer,16556646
12,6,22.0,Back pain,16556646
0,1,22.0,Acinetobacter test positive,16556661
1,1,22.0,Acute kidney injury,16556661
2,1,22.0,Staphylococcal infection,16556661
3,1,22.0,Enterococcal infection,16556661
0,1,22.0,Diarrhoea,16556686
1,1,22.0,Hypotension,16556686
2,1,22.0,Generalised erythema,16556686
3,1,22.0,Pyrexia,16556686
4,1,22.0,Acute kidney injury,16556686
5,1,22.0,Vomiting,16556686
0,6,22.0,Anaphylactic reaction,16556707
1,6,22.0,Nausea,16556707
2,5,22.0,Disease recurrence,16556707
3,5,22.0,Mesenteric artery embolism,16556707
4,5,22.0,Volvulus,16556707
5,6,22.0,Atrial fibrillation,16556707
6,5,22.0,Pulmonary embolism,16556707
7,6,22.0,Neutropenia,16556707
8,6,22.0,Skin toxicity,16556707
9,5,22.0,Salivary gland neoplasm,16556707
10,5,22.0,Cerebrovascular accident,16556707
11,6,22.0,Anaemia,16556707
12,6,22.0,Fatigue,16556707
13,5,22.0,Post procedural complication,16556707
14,6,22.0,Vomiting,16556707
15,6,22.0,Off label use,16556707
16,5,22.0,Intestinal ischaemia,16556707
17,6,22.0,Thrombocytopenia,16556707
18,6,22.0,Diarrhoea,16556707
19,6,22.0,Bone marrow failure,16556707
20,6,22.0,Decreased appetite,16556707
0,6,22.0,Unevaluable event,16556776
0,6,22.1,Fatigue,16556781
1,6,22.1,Hot flush,16556781
2,6,22.1,Myocardial infarction,16556781
0,1,22.0,Muscle spasms,16556854
1,6,22.0,Dizziness,16556854
2,1,22.0,Muscular weakness,16556854
3,6,22.0,Hypoaesthesia,16556854
0,1,22.1,Pericardial haemorrhage,16556860
0,6,22.0,Diarrhoea,16556872
1,6,22.0,Nausea,16556872
2,6,22.0,Vomiting,16556872
0,6,22.0,Enteritis,16556896
0,1,22.1,Ascites,16556900
1,1,22.1,Pericardial effusion,16556900
2,1,22.1,Pleural effusion,16556900
0,2,22.0,Gastrointestinal disorder,16556925
1,6,22.0,Pyrexia,16556925
2,6,22.0,Rash,16556925
0,6,22.0,Back pain,16556941
1,6,22.0,Groin pain,16556941
2,6,22.0,Chills,16556941
0,1,22.1,Encephalopathy,16557042
0,6,22.0,Therapy cessation,16557046
1,6,22.0,Off label use,16557046
0,6,22.0,Rash,16557052
1,6,22.0,Stomatitis,16557052
2,6,22.0,Vaginal infection,16557052
3,6,22.0,Pruritus,16557052
0,6,22.1,Interstitial lung disease,16557064
0,1,22.1,Pulmonary embolism,16557076
0,6,22.0,Tachyphrenia,16557096
1,6,22.0,Feeling abnormal,16557096
2,6,22.0,Dizziness,16557096
3,6,22.0,Dyspnoea,16557096
4,6,22.0,Heart rate abnormal,16557096
0,6,22.0,Knee operation,16557097
0,,22.0,Hospitalisation,16557102
1,,22.0,Blood magnesium increased,16557102
2,,22.0,General physical health deterioration,16557102
3,,22.0,Blood potassium increased,16557102
4,,22.0,Asthenia,16557102
5,,22.0,Product dose omission,16557102
6,,22.0,Decreased appetite,16557102
7,,22.0,Retching,16557102
8,,22.0,Off label use,16557102
9,,22.0,Blood pressure increased,16557102
10,,22.0,Blood creatinine increased,16557102
0,6,22.1,Influenza,16557105
1,6,22.1,Pneumonia,16557105
2,6,22.1,Intentional dose omission,16557105
3,6,22.1,Cellulitis,16557105
0,2,22.0,Intestinal obstruction,16557109
1,3,22.0,Vomiting,16557109
2,5,22.0,Death,16557109
3,3,22.0,Inflammation,16557109
4,3,22.0,Psychiatric symptom,16557109
0,3,22.1,Hyperbilirubinaemia,16557111
1,3,22.1,Anaemia,16557111
0,1,22.0,Delirium,16557118
1,3,22.0,Drug ineffective,16557118
2,6,22.0,Anxiety,16557118
0,6,22.0,Drug ineffective,16557128
0,1,22.0,Malignant neoplasm progression,16557163
1,1,22.0,Neutropenia,16557163
0,1,22.0,Bone marrow failure,16557270
0,6,22.1,Drug interaction,16557283
1,2,22.1,Haematuria,16557283
2,6,22.1,Prescribed underdose,16557283
0,6,22.0,Metastases to lung,16557284
1,3,22.0,Platelet count decreased,16557284
2,1,22.0,Epistaxis,16557284
3,6,22.0,Metastases to central nervous system,16557284
0,1,22.0,Pulmonary alveolar haemorrhage,16557293
0,1,22.0,Platelet count decreased,16557309
1,6,22.0,Blood potassium increased,16557309
2,1,22.0,Renal impairment,16557309
3,6,22.0,C-reactive protein increased,16557309
4,6,22.0,Haematocrit decreased,16557309
5,6,22.0,White blood cell count decreased,16557309
6,6,22.0,Red blood cell count decreased,16557309
7,6,22.0,Haemoglobin decreased,16557309
0,2,22.0,Cardiac failure,16557312
0,5,22.0,Sudden death,16557317
0,,22.0,Spinal compression fracture,16557332
1,1,22.0,Back pain,16557332
0,3,22.0,Lung infiltration,16557334
1,3,22.0,Respiratory failure,16557334
2,3,22.0,Inflammation,16557334
3,3,22.0,Diarrhoea,16557334
4,3,22.0,Acute respiratory distress syndrome,16557334
5,3,22.0,Depressed level of consciousness,16557334
6,3,22.0,General physical health deterioration,16557334
7,3,22.0,Bone marrow failure,16557334
8,3,22.0,Cardiac failure,16557334
9,3,22.0,Toxicity to various agents,16557334
10,3,22.0,Stomatitis,16557334
11,3,22.0,Blood pressure decreased,16557334
0,5,22.0,Pneumonia,16557339
0,5,22.1,Asthma,16557354
0,6,22.0,Neurotoxicity,16557415
1,6,22.0,Stomatitis,16557415
2,6,22.0,Off label use,16557415
3,1,22.0,Haematotoxicity,16557415
4,1,22.0,Metastases to lung,16557415
5,6,22.0,Vaginal fistula,16557415
6,6,22.0,Mucosal toxicity,16557415
0,3,22.1,Vomiting,16557443
1,3,22.1,Pain in extremity,16557443
2,1,22.1,Cough,16557443
3,3,22.1,Nausea,16557443
4,1,22.1,Cellulitis,16557443
5,3,22.1,Abdominal pain,16557443
6,1,22.1,Tooth extraction,16557443
7,3,22.1,Urinary tract infection,16557443
8,3,22.1,Ejection fraction decreased,16557443
9,1,22.1,Abdominal pain lower,16557443
10,1,22.1,Headache,16557443
11,2,22.1,Superinfection,16557443
12,1,22.1,Lower respiratory tract infection,16557443
13,3,22.1,Swelling face,16557443
14,3,22.1,Headache,16557443
15,3,22.1,Asthenia,16557443
16,6,22.1,Mouth swelling,16557443
17,6,22.1,Mouth swelling,16557443
0,6,22.0,Blood sodium decreased,16557447
1,6,22.0,Upper limb fracture,16557447
2,6,22.0,Diarrhoea,16557447
3,6,22.0,Fall,16557447
0,1,22.1,Tendonitis,16557521
0,1,22.0,Neutrophil count decreased,16557523
1,6,22.0,Infection,16557523
2,1,22.0,Pneumonia,16557523
3,3,22.0,Blood lactate dehydrogenase increased,16557523
4,3,22.0,Hyponatraemia,16557523
5,3,22.0,Platelet count decreased,16557523
6,3,22.0,Anaemia,16557523
7,3,22.0,Neuropathy peripheral,16557523
8,1,22.0,Decreased appetite,16557523
9,1,22.0,Nausea,16557523
10,6,22.0,Underdose,16557523
0,2,22.1,Gastrointestinal injury,16557531
1,2,22.1,Procedural complication,16557531
2,2,22.1,Mesenteric haemorrhage,16557531
0,6,22.0,Rhabdomyolysis,16557539
1,3,22.0,Asthenia,16557539
0,6,22.0,Uveitis,16557644
1,6,22.0,Spinal fracture,16557644
0,1,22.0,Dysphonia,16557647
1,1,22.0,Paraesthesia oral,16557647
2,1,22.0,Loss of consciousness,16557647
3,1,22.0,Headache,16557647
4,1,22.0,Throat tightness,16557647
5,1,22.0,Hypotension,16557647
0,6,22.0,Pyoderma gangrenosum,16557695
0,6,22.0,Blood glucose increased,16557840
1,2,22.0,Left ventricular failure,16557840
2,6,22.0,Haemoglobin decreased,16557840
3,6,22.0,Blood creatinine increased,16557840
4,4,22.0,Acute coronary syndrome,16557840
5,6,22.0,Blood urea increased,16557840
0,5,22.1,Malignant neoplasm progression,16557928
1,2,22.1,Lung disorder,16557928
0,1,22.0,Enterocolitis,16557961
0,6,22.1,Tonsillar disorder,16557973
1,6,22.1,Lower limb fracture,16557973
2,6,22.1,Nasal disorder,16557973
0,3,22.0,Adrenal insufficiency,16558009
1,3,22.0,Malignant neoplasm progression,16558009
0,6,22.1,Therapy partial responder,16558030
1,6,22.1,Immune-mediated adverse reaction,16558030
2,6,22.1,Rash,16558030
0,6,22.0,White blood cell count abnormal,16558065
0,1,22.0,Cystitis,16558146
1,3,22.0,Hot flush,16558146
2,1,22.0,Lacrimation increased,16558146
3,1,22.0,Bone pain,16558146
4,1,22.0,Libido decreased,16558146
5,1,22.0,Alopecia,16558146
6,1,22.0,Nasopharyngitis,16558146
7,1,22.0,Taste disorder,16558146
8,3,22.0,Fatigue,16558146
9,1,22.0,Polyneuropathy,16558146
10,1,22.0,Mucosal inflammation,16558146
11,1,22.0,Palmar-plantar erythrodysaesthesia syndrome,16558146
0,6,22.0,Inappropriate schedule of product administration,16558208
1,5,22.0,Malignant neoplasm progression,16558208
2,6,22.0,Inappropriate schedule of product administration,16558208
3,6,22.0,Inappropriate schedule of product administration,16558208
0,3,22.0,Diarrhoea,16558242
1,3,22.0,General physical health deterioration,16558242
2,3,22.0,Cardiac failure,16558242
3,6,22.0,Bone pain,16558242
4,3,22.0,Respiratory failure,16558242
5,3,22.0,Bone marrow failure,16558242
6,3,22.0,Stomatitis,16558242
7,3,22.0,Inflammation,16558242
8,3,22.0,Acute respiratory distress syndrome,16558242
9,3,22.0,Toxicity to various agents,16558242
10,6,22.0,Off label use,16558242
11,3,22.0,Lung infiltration,16558242
12,3,22.0,Blood pressure decreased,16558242
13,3,22.0,Depressed level of consciousness,16558242
0,3,22.0,Lung disorder,16558334
0,1,22.0,Mydriasis,16558372
1,1,22.0,Loss of consciousness,16558372
2,1,22.0,Anaphylactic shock,16558372
0,1,22.0,Haemophagocytic lymphohistiocytosis,16558375
0,6,22.0,Ilium fracture,16558402
1,6,22.0,Alopecia,16558402
2,2,22.0,Neutrophil count decreased,16558402
3,6,22.0,Anaemia,16558402
0,1,22.0,Bone marrow failure,16558434
0,2,22.0,Nausea,16558436
1,2,22.0,Loss of consciousness,16558436
2,2,22.0,Syncope,16558436
3,2,22.0,Head injury,16558436
0,1,22.0,Hyponatraemia,16558523
1,6,22.0,Prescribed underdose,16558523
2,3,22.0,Fall,16558523
3,3,22.0,Spinal cord injury,16558523
0,5,22.0,Death,16558528
0,2,22.0,Asthenia,16558535
1,2,22.0,Neutropenia,16558535
0,1,22.0,Cognitive disorder,16558537
1,1,22.0,Vitamin B1 deficiency,16558537
2,6,22.0,Hyponatraemia,16558537
3,6,22.0,Toxicity to various agents,16558537
4,6,22.0,Dehydration,16558537
5,6,22.0,Decreased appetite,16558537
6,2,22.0,Diarrhoea,16558537
7,6,22.0,Vomiting,16558537
8,6,22.0,Anaemia,16558537
0,6,22.0,Osteonecrosis of jaw,16558556
1,6,22.0,Fistula,16558556
2,6,22.0,Jaw fracture,16558556
3,6,22.0,Pathological fracture,16558556
0,1,22.0,Hypoglycaemia,16558560
1,6,22.0,Drug interaction,16558560
0,6,22.0,Rash,16558578
1,6,22.0,Transaminases increased,16558578
2,6,22.0,Anaphylactic reaction,16558578
0,3,22.0,Granulocytopenia,16558591
0,3,22.0,Inflammation,16558602
1,3,22.0,Blood pressure decreased,16558602
2,3,22.0,Diarrhoea,16558602
3,3,22.0,Respiratory failure,16558602
4,3,22.0,Cardiac failure,16558602
5,3,22.0,Lung infiltration,16558602
6,3,22.0,General physical health deterioration,16558602
7,3,22.0,Depressed level of consciousness,16558602
8,3,22.0,Bone marrow failure,16558602
9,3,22.0,Stomatitis,16558602
10,3,22.0,Acute respiratory distress syndrome,16558602
0,6,22.0,Syncope,16558608
1,6,22.0,Nasopharyngitis,16558608
2,6,22.0,Blood pressure decreased,16558608
3,6,22.0,General physical health deterioration,16558608
0,5,22.0,Death,16558615
1,5,22.0,Respiratory failure,16558615
2,6,22.0,Off label use,16558615
3,5,22.0,Hypocalcaemia,16558615
4,5,22.0,Thrombocytopenia,16558615
5,5,22.0,Hypoalbuminaemia,16558615
6,6,22.0,Incorrect route of product administration,16558615
7,5,22.0,Seizure,16558615
0,5,22.0,Death,16558619
0,6,22.0,Hepatitis B surface antibody positive,16558626
0,1,22.0,Rash pruritic,16558643
1,1,22.0,Rash erythematous,16558643
0,6,22.0,Catheter placement,16558675
1,6,22.0,Adverse event,16558675
2,6,22.0,Product use in unapproved indication,16558675
3,5,22.0,Multiple organ dysfunction syndrome,16558675
4,5,22.0,Malignant neoplasm progression,16558675
5,6,22.0,Tumour excision,16558675
6,6,22.0,Abscess drainage,16558675
0,6,22.0,Malaise,16558686
1,5,22.0,Toxicity to various agents,16558686
0,5,22.0,Death,16558710
0,6,22.0,Renal impairment,16558820
1,6,22.0,Blood bilirubin increased,16558820
0,6,22.0,Rash,16558913
1,6,22.0,Dermatitis,16558913
0,3,22.0,Fatigue,16558926
1,6,22.0,Nasopharyngitis,16558926
2,1,22.0,Hypertension,16558926
3,3,22.0,Weight increased,16558926
4,3,22.0,Constipation,16558926
0,3,22.0,Lethargy,16559002
1,3,22.0,Arthralgia,16559002
2,3,22.0,Underdose,16559002
3,3,22.0,Fatigue,16559002
4,3,22.0,Increased tendency to bruise,16559002
0,3,22.0,Fatigue,16559067
1,6,22.0,Product dose omission,16559067
0,1,22.0,Hypotension,16559196
1,1,22.0,Hypersensitivity,16559196
2,1,22.0,Tachycardia,16559196
3,1,22.0,Abdominal pain,16559196
0,5,22.1,Malignant neoplasm progression,16559310
0,2,22.0,Fall,16559336
1,6,22.0,Malignant neoplasm progression,16559336
0,,22.0,Diarrhoea,16559356
0,6,22.0,Blood bilirubin increased,16559379
1,6,22.0,Condition aggravated,16559379
0,6,22.0,Malignant neoplasm progression,16559422
1,6,22.0,Intentional product use issue,16559422
0,6,22.0,Lymphadenopathy,16559479
1,6,22.0,Hypergammaglobulinaemia,16559479
2,1,22.0,Visceral leishmaniasis,16559479
3,1,22.0,Pancytopenia,16559479
4,6,22.0,Splenomegaly,16559479
5,6,22.0,Hypoalbuminaemia,16559479
6,6,22.0,Chordae tendinae rupture,16559479
7,6,22.0,Hepatomegaly,16559479
0,6,22.0,Chest pain,16559513
1,6,22.0,Erythema,16559513
2,6,22.0,Dyspnoea,16559513
3,6,22.0,Feeling hot,16559513
4,6,22.0,Off label use,16559513
5,6,22.0,Hypotension,16559513
6,1,22.0,Infusion related reaction,16559513
7,6,22.0,Abdominal pain upper,16559513
0,1,22.0,Neutropenia,16559568
1,1,22.0,Blood pressure increased,16559568
0,6,22.0,Intentional product use issue,16559574
1,5,22.0,Death,16559574
0,6,22.0,Heart rate decreased,16559601
0,6,22.0,Thrombocytopenia,16559613
1,6,22.0,Perineal disorder,16559613
2,6,22.0,Diarrhoea,16559613
3,6,22.0,Skin reaction,16559613
4,6,22.0,Stomatitis,16559613
5,6,22.0,Neutropenia,16559613
6,6,22.0,Off label use,16559613
0,,22.0,Vomiting,16559618
1,,22.0,Asthenia,16559618
2,,22.0,Loss of personal independence in daily activities,16559618
0,,22.0,Diarrhoea,16559638
0,2,22.1,Hypertension,16559708
1,6,22.1,Hypertensive crisis,16559708
0,6,22.0,Full blood count abnormal,16559718
1,6,22.0,Platelet count decreased,16559718
0,6,22.0,Neoplasm progression,16559734
0,6,22.0,Malignant neoplasm progression,16559743
1,6,22.0,Breast cancer,16559743
0,2,22.0,Acute kidney injury,16559752
1,3,22.0,Thrombocytopenia,16559752
2,3,22.0,Dysphagia,16559752
3,1,22.0,Hypokalaemia,16559752
4,3,22.0,Mucosal inflammation,16559752
5,1,22.0,Agranulocytosis,16559752
0,3,22.1,Madarosis,16559796
1,3,22.1,Alopecia,16559796
0,1,22.1,Back pain,16559809
0,,22.0,Product availability issue,16559831
1,,22.0,Therapy cessation,16559831
0,,22.0,Death,16559847
0,2,22.0,Skin ulcer,16559854
1,2,22.0,Condition aggravated,16559854
0,5,22.0,Malignant neoplasm progression,16559912
1,1,22.0,Hepatic function abnormal,16559912
0,3,22.0,Hormone-refractory prostate cancer,16559931
0,1,22.1,Pneumonia,16559934
1,2,22.1,N-terminal prohormone brain natriuretic peptide increased,16559934
2,6,22.1,Renal impairment,16559934
3,1,22.1,Pulmonary oedema,16559934
4,2,22.1,Blood thyroid stimulating hormone increased,16559934
5,6,22.1,Creatinine renal clearance decreased,16559934
0,6,22.0,Haemoglobin decreased,16559948
0,3,22.0,Ileus paralytic,16559961
0,3,22.0,Hormone level abnormal,16560036
1,3,22.0,Balance disorder,16560036
2,3,22.0,Flushing,16560036
3,3,22.0,Malaise,16560036
4,6,22.0,Nausea,16560036
5,6,22.0,Loss of consciousness,16560036
6,3,22.0,Feeling of body temperature change,16560036
7,3,22.0,Arthralgia,16560036
8,6,22.0,Dizziness,16560036
9,3,22.0,Arthropathy,16560036
10,3,22.0,Hyperhidrosis,16560036
11,6,22.0,Stress,16560036
0,6,22.1,Lacrimation increased,16560052
1,6,22.1,Dysuria,16560052
2,6,22.1,Abdominal pain,16560052
3,6,22.1,Fatigue,16560052
0,2,22.0,Interstitial lung disease,16560060
1,6,22.0,Bladder cancer,16560060
0,5,22.0,Death,16560062
0,6,22.0,Off label use,16560267
1,3,22.0,Malignant neoplasm progression,16560267
0,6,22.0,Psychological trauma,16560358
1,3,22.0,Alopecia,16560358
0,5,22.0,Myocardial infarction,16560360
0,2,22.0,Alopecia,16560368
0,2,22.0,Pleural effusion,16560517
0,1,22.0,Pituitary tumour benign,16560520
0,1,22.0,Dysphagia,16560559
1,1,22.0,Pyrexia,16560559
2,1,22.0,Disseminated Bacillus Calmette-Guerin infection,16560559
3,1,22.0,Odynophagia,16560559
4,1,22.0,Pain,16560559
5,6,22.0,Infected neoplasm,16560559
0,2,22.0,Skin exfoliation,16560617
1,2,22.0,Nausea,16560617
2,2,22.0,Gastrointestinal disorder,16560617
0,6,22.0,Bedridden,16560624
1,6,22.0,Myalgia,16560624
0,6,22.0,Hypoglycaemia,16560627
1,6,22.0,Drug interaction,16560627
0,6,22.0,Fatigue,16560628
1,6,22.0,Diarrhoea,16560628
2,6,22.0,Rash,16560628
3,6,22.0,Ageusia,16560628
4,6,22.0,Decreased appetite,16560628
0,5,22.0,Death,16560632
0,3,22.0,Pulmonary embolism,16560688
0,6,22.0,Intestinal obstruction,16560705
0,1,22.0,Ischaemic stroke,16560712
0,6,22.0,Psychological trauma,16560724
1,2,22.0,Alopecia,16560724
0,6,22.0,Hypertension,16560747
1,6,22.0,Thrombocytopenia,16560747
2,6,22.0,Fatigue,16560747
3,6,22.0,Anaemia,16560747
4,6,22.0,Neutropenia,16560747
5,6,22.0,Neurotoxicity,16560747
6,6,22.0,Asthenia,16560747
0,1,22.1,Interstitial lung disease,16560756
1,6,22.1,Interstitial lung disease,16560756
2,2,22.1,Nephritis,16560756
3,2,22.1,Hypophysitis,16560756
4,2,22.1,Renal failure,16560756
5,2,22.1,Adrenal insufficiency,16560756
0,3,22.0,Alopecia,16560780
1,6,22.0,Psychological trauma,16560780
0,5,22.0,Respiratory depression,16560801
1,5,22.0,Lung neoplasm malignant,16560801
2,5,22.0,Disease progression,16560801
0,1,22.0,Gamma-glutamyltransferase increased,16560911
0,6,22.0,Off label use,16561174
1,6,22.0,Tubulointerstitial nephritis,16561174
2,5,22.0,Malignant neoplasm progression,16561174
0,1,22.0,Neutropenia,16561200
1,6,22.0,Gamma-glutamyltransferase increased,16561200
2,4,22.0,Hepatic failure,16561200
3,6,22.0,Alanine aminotransferase increased,16561200
4,3,22.0,Peripheral sensory neuropathy,16561200
5,1,22.0,Nausea,16561200
6,3,22.0,Fatigue,16561200
7,6,22.0,Aspartate aminotransferase increased,16561200
8,1,22.0,Rash maculo-papular,16561200
9,1,22.0,Cough,16561200
0,1,22.0,Hypotension,16561238
1,1,22.0,Vertigo,16561238
2,1,22.0,Hyperhidrosis,16561238
3,1,22.0,Oxygen saturation decreased,16561238
0,1,22.0,White blood cell count decreased,16561271
1,1,22.0,Renal impairment,16561271
0,6,22.0,Anxiety,16561329
1,6,22.0,Dizziness,16561329
2,2,22.0,Asthenia,16561329
3,3,22.0,Insomnia,16561329
4,6,22.0,Arthralgia,16561329
5,6,22.0,Pollakiuria,16561329
6,6,22.0,Fatigue,16561329
7,2,22.0,Chest discomfort,16561329
8,2,22.0,Dyspnoea,16561329
9,2,22.0,Dizziness,16561329
10,2,22.0,Myalgia,16561329
11,6,22.0,Decreased appetite,16561329
12,6,22.0,General physical health deterioration,16561329
13,6,22.0,Urinary incontinence,16561329
14,2,22.0,Tachycardia,16561329
15,6,22.0,Feeling abnormal,16561329
16,6,22.0,Depression,16561329
17,6,22.0,Bone pain,16561329
18,6,22.0,Chest pain,16561329
19,6,22.0,Urinary retention,16561329
20,3,22.0,Nausea,16561329
21,6,22.0,Constipation,16561329
0,3,22.0,Decreased appetite,16561330
1,3,22.0,Constipation,16561330
2,3,22.0,Dizziness,16561330
3,3,22.0,Asthenia,16561330
4,6,22.0,Muscle twitching,16561330
5,3,22.0,Fatigue,16561330
6,6,22.0,Neuropathy peripheral,16561330
7,3,22.0,Insomnia,16561330
8,3,22.0,Restless legs syndrome,16561330
9,6,22.0,Ageusia,16561330
10,3,22.0,Rhinorrhoea,16561330
11,6,22.0,Headache,16561330
12,3,22.0,Anxiety,16561330
13,3,22.0,Taste disorder,16561330
14,3,22.0,Hot flush,16561330
15,3,22.0,Amnesia,16561330
16,3,22.0,Depressed level of consciousness,16561330
0,6,22.0,Fall,16561346
1,2,22.0,Nausea,16561346
2,6,22.0,Vomiting,16561346
3,6,22.0,Oral pain,16561346
4,6,22.0,Cerebrovascular accident,16561346
5,6,22.0,Abdominal discomfort,16561346
6,6,22.0,Tongue injury,16561346
7,6,22.0,Off label use,16561346
8,5,22.0,Death,16561346
9,6,22.0,Hip fracture,16561346
0,5,22.0,Malaise,16561364
1,5,22.0,Death,16561364
2,5,22.0,Dehydration,16561364
3,5,22.0,Bone pain,16561364
4,5,22.0,Pain in jaw,16561364
0,5,22.0,Death,16561379
0,6,22.0,Metastases to central nervous system,16561422
1,6,22.0,Off label use,16561422
2,6,22.0,Intentional product use issue,16561422
0,6,22.0,Product use in unapproved indication,16561427
1,6,22.0,Malignant neoplasm progression,16561427
2,6,22.0,Gastric cancer,16561427
0,1,22.0,Fall,16561443
1,6,22.0,Pruritus,16561443
2,6,22.0,Blister,16561443
3,1,22.0,Gastrointestinal haemorrhage,16561443
4,1,22.0,Tibia fracture,16561443
5,1,22.0,Fibula fracture,16561443
0,3,22.0,General physical health deterioration,16561448
1,3,22.0,Abdominal distension,16561448
2,3,22.0,Asthenia,16561448
0,1,22.0,Electrocardiogram QT prolonged,16561454
0,1,22.0,Dizziness,16561456
1,1,22.0,Flushing,16561456
2,1,22.0,Infusion related reaction,16561456
0,6,22.0,Colitis ischaemic,16561467
0,6,22.0,Malignant neoplasm progression,16561469
1,6,22.0,Product use in unapproved indication,16561469
2,6,22.0,HER-2 positive gastric cancer,16561469
0,2,22.0,Pulmonary fibrosis,16561479
1,2,22.0,Tachypnoea,16561479
2,2,22.0,Dyspnoea,16561479
3,2,22.0,Pneumonia,16561479
4,2,22.0,Pneumonitis,16561479
5,6,22.0,Product use in unapproved indication,16561479
6,2,22.0,Cough,16561479
0,1,22.0,Dyspnoea,16561493
1,1,22.0,Erythema,16561493
0,1,22.0,Cerebral infarction,16561515
1,2,22.0,Pleural effusion,16561515
2,5,22.0,Respiratory failure,16561515
3,1,22.0,Cerebrovascular accident,16561515
4,5,22.0,Neoplasm progression,16561515
5,5,22.0,Pneumonia,16561515
0,6,22.0,Cerebrovascular accident,16561523
0,6,22.0,Infection,16561539
0,6,22.0,Product dose omission,16561595
1,6,22.0,Product label issue,16561595
0,5,22.0,Death,16561628
0,6,22.0,Knee arthroplasty,16561629
1,2,22.0,Fatigue,16561629
0,1,22.0,Neutropenia,16561886
0,1,22.0,Hepatitis B reactivation,16561958
1,2,22.0,Hepatitis,16561958
0,1,22.0,Visceral leishmaniasis,16561965
0,2,22.0,Myocarditis,16561969
1,6,22.0,Cardiac failure,16561969
2,2,22.0,Hypothyroidism,16561969
3,6,22.0,Atrioventricular block complete,16561969
0,1,22.0,Insomnia,16561974
1,6,22.0,Dysgeusia,16561974
2,4,22.0,Peripheral sensory neuropathy,16561974
3,4,22.0,Stomatitis,16561974
4,6,22.0,Myalgia,16561974
5,3,22.0,Rhinitis,16561974
6,6,22.0,Arthralgia,16561974
7,1,22.0,Diarrhoea,16561974
8,3,22.0,Hepatic failure,16561974
0,2,22.0,Hepatic lesion,16562030
1,,22.0,Palmar-plantar erythrodysaesthesia syndrome,16562030
2,2,22.0,Jaundice cholestatic,16562030
3,,22.0,Urethritis,16562030
4,,22.0,Inappropriate schedule of product administration,16562030
5,,22.0,Lymphadenopathy,16562030
6,,22.0,Carcinoembryonic antigen increased,16562030
7,,22.0,Palmar-plantar erythrodysaesthesia syndrome,16562030
0,6,22.0,Thyroiditis,16562044
1,3,22.0,Hypokalaemia,16562044
2,3,22.0,Hypercalcaemia,16562044
3,6,22.0,Basedow^s disease,16562044
4,3,22.0,Hyperthyroidism,16562044
0,2,22.0,Lipase increased,16562049
1,2,22.0,Amylase increased,16562049
0,1,22.0,Product use in unapproved indication,16562064
1,6,22.0,Nausea,16562064
2,6,22.0,Insomnia,16562064
3,6,22.0,Dehydration,16562064
4,6,22.0,Malaise,16562064
0,6,22.1,Choking,16562087
1,6,22.1,Swelling,16562087
2,6,22.1,Product coating issue,16562087
3,2,22.1,Hypertension,16562087
4,6,22.1,Neuropathy peripheral,16562087
0,5,22.0,Neoplasm progression,16562117
0,1,22.0,Mucosal toxicity,16562159
1,1,22.0,Toxicity to various agents,16562159
2,1,22.0,Palmar-plantar erythrodysaesthesia syndrome,16562159
0,2,22.0,Hepatitis acute,16562330
0,2,22.0,Myalgia,16562360
1,2,22.0,Arthralgia,16562360
2,1,22.0,Orthostatic hypotension,16562360
3,1,22.0,Dizziness,16562360
4,2,22.0,Flushing,16562360
5,2,22.0,Abdominal pain,16562360
0,6,22.0,Coronary artery occlusion,16562380
1,6,22.0,Procedural complication,16562380
2,3,22.0,Chest pain,16562380
0,4,22.0,Migraine,16562398
1,4,22.0,Diarrhoea,16562398
2,4,22.0,Dehydration,16562398
0,2,22.0,Acute febrile neutrophilic dermatosis,16562420
0,1,22.0,Hepatocellular injury,16562440
0,5,22.0,Death,16562595
1,6,22.0,Cardio-respiratory arrest,16562595
0,1,22.1,Neutropenia,16562598
0,6,22.0,Metastases to bone,16562685
0,5,22.1,Interstitial lung disease,16562697
0,5,22.0,Neoplasm progression,16562732
1,6,22.0,Sepsis,16562732
0,5,22.1,Respiratory failure,16562734
0,6,22.1,Product availability issue,16562754
1,3,22.1,Bladder cancer recurrent,16562754
0,3,22.0,Diarrhoea,16563000
1,3,22.0,Nail disorder,16563000
0,6,22.0,Accidental overdose,16563032
1,1,22.0,Vision blurred,16563032
2,1,22.0,Feeling hot,16563032
3,3,22.0,Renal impairment,16563032
4,1,22.0,Tinnitus,16563032
0,5,22.1,Interstitial lung disease,16563047
1,6,22.1,Off label use,16563047
0,6,22.0,Treatment failure,16563069
0,6,22.0,Drug ineffective,16563087
0,6,22.0,Off label use,16563106
1,1,22.0,Leukopenia,16563106
0,1,22.0,Leukopenia,16563107
1,6,22.0,Off label use,16563107
0,1,22.0,Cardiac failure,16563122
0,3,22.0,Neutropenia,16563125
1,6,22.0,Off label use,16563125
0,6,22.0,Abdominal pain upper,16563185
1,6,22.0,Dyspepsia,16563185
2,6,22.0,Vomiting,16563185
0,6,22.0,Blood pressure increased,16563250
1,6,22.0,Transient ischaemic attack,16563250
2,6,22.0,Reversible ischaemic neurological deficit,16563250
3,6,22.0,Tinnitus,16563250
4,6,22.0,Mitral valve incompetence,16563250
5,6,22.0,Extrasystoles,16563250
0,6,22.0,Nephrotic syndrome,16563267
1,6,22.0,Metastases to peritoneum,16563267
2,6,22.0,Metastases to lymph nodes,16563267
0,6,22.0,Metastases to lymph nodes,16563295
1,6,22.0,Visual impairment,16563295
2,6,22.0,Ascites,16563295
3,6,22.0,Ovarian cancer,16563295
4,6,22.0,Malignant neoplasm progression,16563295
5,6,22.0,Metastases to lung,16563295
6,6,22.0,Metastases to ovary,16563295
7,6,22.0,Metastases to central nervous system,16563295
0,1,22.0,Muscle spasms,16563308
0,5,22.0,Death,16563323
0,3,22.0,Disease progression,16563358
1,3,22.0,Colon cancer,16563358
0,2,22.0,Liver disorder,16563485
1,6,22.0,Intentional product use issue,16563485
0,6,22.0,Constipation,16563491
1,6,22.0,Dehydration,16563491
2,6,22.0,Nausea,16563491
3,6,22.0,Fatigue,16563491
4,6,22.0,Abdominal pain upper,16563491
0,3,22.0,Back pain,16563492
1,1,22.0,Lung infection,16563492
0,1,22.1,Pneumocystis jirovecii pneumonia,16563493
1,2,22.1,Arthralgia,16563493
2,2,22.1,Hot flush,16563493
3,1,22.1,Dyspnoea,16563493
4,3,22.1,Nausea,16563493
5,1,22.1,Influenza,16563493
6,2,22.1,Cardiac disorder,16563493
7,2,22.1,Fatigue,16563493
8,2,22.1,Headache,16563493
0,6,22.0,Nausea,16563496
1,6,22.0,Blood phosphorus decreased,16563496
0,5,22.0,Death,16563502
0,1,22.0,Disseminated intravascular coagulation,16563507
1,6,22.0,Neoplasm progression,16563507
2,1,22.0,Thrombocytopenia,16563507
0,5,22.0,Renal failure,16563546
1,5,22.0,Diarrhoea,16563546
0,3,22.0,Abdominal distension,16563573
1,3,22.0,General physical health deterioration,16563573
2,3,22.0,Asthenia,16563573
0,6,22.0,Sarcoidosis,16563586
0,1,22.0,Testicular perforation,16563599
1,1,22.0,Fournier^s gangrene,16563599
0,1,22.0,Pneumonitis,16563647
1,2,22.0,Arthralgia,16563647
0,2,22.0,Renal failure,16563663
1,1,22.0,Haematuria,16563663
2,1,22.0,Blood loss anaemia,16563663
3,6,22.0,Prostatic specific antigen increased,16563663
0,6,22.0,Cholecystitis acute,16563664
0,3,22.0,Pyrexia,16563702
1,3,22.0,Rash generalised,16563702
0,6,22.0,Neutropenia,16563736
1,6,22.0,Nausea,16563736
2,6,22.0,Asthenia,16563736
3,6,22.0,Thrombocytopenia,16563736
4,6,22.0,Vomiting,16563736
5,6,22.0,Paraesthesia,16563736
6,6,22.0,Mucosal inflammation,16563736
7,6,22.0,Diarrhoea,16563736
8,6,22.0,Neurotoxicity,16563736
0,6,22.0,Brain neoplasm,16563754
1,6,22.0,Treatment failure,16563754
0,1,22.0,Malaise,16563756
0,3,22.0,Renal failure,16563759
0,6,22.1,Hepatic steatosis,16563771
1,6,22.1,Skin exfoliation,16563771
2,6,22.1,Drug interaction,16563771
3,3,22.1,Metastases to liver,16563771
4,6,22.1,Drug ineffective,16563771
5,6,22.1,Palmar-plantar erythrodysaesthesia syndrome,16563771
0,2,22.0,Hyperglycaemia,16563772
0,1,22.0,Hypokalaemia,16563807
0,3,22.0,Pulmonary hypertension,16563840
0,2,22.0,Ureteric obstruction,16563841
0,5,22.0,Death,16563854
0,6,22.0,Malignant neoplasm progression,16563856
1,6,22.0,Drug resistance,16563856
0,6,22.0,Platelet count decreased,16563859
1,6,22.0,Biliary tract infection,16563859
2,6,22.0,Jaundice,16563859
3,6,22.0,Biliary dilatation,16563859
4,6,22.0,Bile duct stenosis,16563859
5,6,22.0,Hyperpyrexia,16563859
0,6,22.0,Haemoptysis,16563863
1,6,22.0,Blood glucose increased,16563863
2,5,22.0,Death,16563863
0,1,22.0,Muscle spasms,16563885
1,6,22.0,Dizziness,16563885
2,6,22.0,Hypoaesthesia,16563885
3,1,22.0,Muscular weakness,16563885
0,6,22.0,Colony stimulating factor therapy,16563894
0,6,22.1,Fatigue,16563957
1,6,22.1,Muscular weakness,16563957
2,6,22.1,Oesophagitis,16563957
3,6,22.1,Stomatitis,16563957
4,1,22.1,Small intestinal obstruction,16563957
0,5,22.0,Death,16563959
0,1,22.0,Infusion site extravasation,16563967
1,6,22.0,Peripheral swelling,16563967
2,6,22.0,Erythema,16563967
3,6,22.0,Blister,16563967
0,3,22.0,Pain in jaw,16563983
1,3,22.0,Malaise,16563983
2,3,22.0,Bone pain,16563983
3,5,22.0,Death,16563983
4,3,22.0,Dehydration,16563983
0,6,22.0,Pleural effusion,16563989
1,6,22.0,Hyponatraemia,16563989
2,6,22.0,Anaemia,16563989
0,6,22.0,Malaise,16564000
0,1,22.0,Oesophageal varices haemorrhage,16564002
0,4,22.0,Epididymitis,16564006
1,1,22.0,Proctitis,16564006
2,3,22.0,Transitional cell carcinoma,16564006
3,6,22.0,Lung disorder,16564006
4,1,22.0,Influenza,16564006
5,3,22.0,Hypothyroidism,16564006
0,6,22.0,Metastases to central nervous system,16564010
1,5,22.0,Malignant neoplasm progression,16564010
2,6,22.0,Intentional product use issue,16564010
0,5,22.0,Death,16564019
0,1,22.0,Hot flush,16564023
1,1,22.0,Heat exhaustion,16564023
2,1,22.0,Dehydration,16564023
3,1,22.0,Loss of consciousness,16564023
0,6,22.0,Condition aggravated,16564143
0,6,22.0,Dehydration,16564169
1,6,22.0,Dysphagia,16564169
2,6,22.0,Mucosal inflammation,16564169
3,6,22.0,Pneumonia aspiration,16564169
4,6,22.0,Pyrexia,16564169
5,6,22.0,Pancytopenia,16564169
0,1,22.0,Hypoxia,16564170
1,2,22.0,Dyspnoea,16564170
2,2,22.0,Pneumonitis,16564170
0,6,22.0,Malignant neoplasm progression,16564177
1,6,22.0,Drug resistance,16564177
0,2,22.0,Cognitive disorder,16564178
1,6,22.0,Decreased appetite,16564178
2,6,22.0,Vomiting,16564178
3,6,22.0,Diarrhoea,16564178
0,6,22.0,Anaemia,16564196
1,6,22.0,Hypoalbuminaemia,16564196
0,6,22.0,Brain neoplasm malignant,16564216
1,5,22.0,Death,16564216
0,6,22.0,Blood creatinine increased,16564255
1,6,22.0,Renal disorder,16564255
2,6,22.0,Renal impairment,16564255
0,1,22.0,Multiple organ dysfunction syndrome,16564322
1,6,22.0,Product prescribing error,16564322
2,6,22.0,Prescribed overdose,16564322
0,1,22.1,Tooth abscess,16564338
1,6,22.1,Weight increased,16564338
2,3,22.1,Visual impairment,16564338
3,6,22.1,Epistaxis,16564338
4,6,22.1,Overdose,16564338
5,6,22.1,Erythema,16564338
6,6,22.1,Malaise,16564338
7,6,22.1,Product use issue,16564338
8,6,22.1,Hot flush,16564338
9,6,22.1,Injection site pain,16564338
10,6,22.1,Endocrine disorder,16564338
11,1,22.1,Asthenia,16564338
0,6,22.0,Traumatic lung injury,16564360
0,1,22.0,Status epilepticus,16564369
1,1,22.0,Seizure,16564369
0,3,22.0,Neuropathy peripheral,16564373
0,1,22.0,Dyspnoea,16564389
1,1,22.0,Erythema,16564389
0,2,22.0,Pancytopenia,16564420
1,1,22.0,Diarrhoea,16564420
2,1,22.0,Pyrexia,16564420
0,6,22.0,Epididymitis,16564435
1,6,22.0,Injection site pain,16564435
2,6,22.0,Hot flush,16564435
0,6,22.0,Axonal neuropathy,16564460
1,6,22.0,Carpal tunnel decompression,16564460
0,2,22.0,Radiation pneumonitis,16564469
0,2,22.0,Anaemia,16564472
1,2,22.0,Interstitial lung disease,16564472
0,6,22.0,Malaise,16564494
1,6,22.0,Extrasystoles,16564494
2,6,22.0,Infusion related reaction,16564494
3,6,22.0,Hypotension,16564494
0,6,22.0,Interstitial lung disease,16564499
0,1,22.1,Pain in extremity,16564519
1,6,22.1,Decreased appetite,16564519
2,6,22.1,Malaise,16564519
3,6,22.1,Skin exfoliation,16564519
4,6,22.1,Acne,16564519
5,6,22.1,Nausea,16564519
6,6,22.1,Oedema peripheral,16564519
7,1,22.1,Skin necrosis,16564519
8,6,22.1,Stevens-Johnson syndrome,16564519
9,6,22.1,Dry skin,16564519
10,6,22.1,Delirium,16564519
11,2,22.1,Rash,16564519
12,6,22.1,Dementia,16564519
13,6,22.1,Sleep disorder due to a general medical condition,16564519
0,1,22.1,Pneumonia,16564521
0,1,22.0,Visceral leishmaniasis,16564612
1,6,22.0,Splenomegaly,16564612
2,6,22.0,Chordae tendinae rupture,16564612
3,1,22.0,Pancytopenia,16564612
4,6,22.0,Hypergammaglobulinaemia,16564612
5,6,22.0,Hypoalbuminaemia,16564612
6,6,22.0,Lymphadenopathy,16564612
7,6,22.0,Hepatomegaly,16564612
0,6,22.0,Vulvovaginal pain,16564629
1,6,22.0,Unevaluable event,16564629
2,6,22.0,Rash pruritic,16564629
3,6,22.0,Vulvovaginal pruritus,16564629
0,6,22.0,Drug resistance,16564632
1,6,22.0,Malignant neoplasm progression,16564632
0,1,22.0,Oesophageal perforation,16564639
1,6,22.0,Infectious pleural effusion,16564639
2,6,22.0,Cytomegalovirus test positive,16564639
3,6,22.0,Malnutrition,16564639
4,6,22.0,Off label use,16564639
5,6,22.0,Diarrhoea,16564639
6,2,22.0,Anastomotic leak,16564639
0,2,22.0,Neuropathy peripheral,16564683
1,2,22.0,Myasthenia gravis,16564683
0,6,22.0,Hypoalbuminaemia,16564686
1,6,22.0,Anaemia,16564686
2,6,22.0,Drug ineffective,16564686
0,1,22.0,Pyrexia,16564688
1,1,22.0,Gravitational oedema,16564688
2,1,22.0,Neutropenia,16564688
0,6,22.0,Lymphadenopathy,16564696
1,6,22.0,Hypergammaglobulinaemia,16564696
2,6,22.0,Hepatomegaly,16564696
3,6,22.0,Splenomegaly,16564696
4,6,22.0,Chordae tendinae rupture,16564696
5,1,22.0,Pancytopenia,16564696
6,1,22.0,Visceral leishmaniasis,16564696
7,6,22.0,Hypoalbuminaemia,16564696
0,2,22.0,Cholestasis,16564713
0,6,22.0,Drug level increased,16564731
1,6,22.0,Drug interaction,16564731
2,1,22.0,Hypoglycaemia,16564731
0,6,22.0,Disease progression,16564799
1,6,22.0,General physical health deterioration,16564799
0,6,22.0,Cholangitis acute,16564803
1,6,22.0,Gastrointestinal toxicity,16564803
2,6,22.0,Haematotoxicity,16564803
0,1,22.0,Myocardial infarction,16564844
0,1,22.0,Chest discomfort,16564874
1,1,22.0,Hypertension,16564874
0,5,22.1,Pneumothorax spontaneous,16564883
1,5,22.1,Interstitial lung disease,16564883
0,6,22.1,Tonsillar disorder,16564900
1,6,22.1,Nasal disorder,16564900
2,6,22.1,Lower limb fracture,16564900
0,1,22.0,Hypoglycaemia,16564901
1,1,22.0,Drug interaction,16564901
0,6,22.0,Drug interaction,16564904
1,6,22.0,Hypoglycaemia,16564904
0,6,22.0,Type 1 diabetes mellitus,16564934
1,6,22.0,Diabetes mellitus inadequate control,16564934
0,6,22.0,Optic neuritis,16564950
0,2,22.0,Lower respiratory tract infection,16564955
1,3,22.0,Poor quality sleep,16564955
2,3,22.0,Restlessness,16564955
3,3,22.0,Decreased appetite,16564955
4,3,22.0,Atrial fibrillation,16564955
5,3,22.0,Glossodynia,16564955
6,3,22.0,Oedema peripheral,16564955
7,3,22.0,Electrocardiogram T wave abnormal,16564955
8,3,22.0,Fatigue,16564955
9,3,22.0,Asthenia,16564955
10,3,22.0,Nausea,16564955
0,6,22.0,Conjunctivitis,16564957
1,6,22.0,Inappropriate schedule of product administration,16564957
0,1,22.1,Nausea,16564970
1,1,22.1,Hyponatraemia,16564970
2,1,22.1,Urinary tract infection bacterial,16564970
3,1,22.1,Decreased appetite,16564970
4,1,22.1,Congestive cardiomyopathy,16564970
5,1,22.1,Cardiac failure,16564970
6,1,22.1,Vomiting,16564970
0,,22.0,Disease progression,16564992
0,6,22.0,Pain in jaw,16564996
1,6,22.0,Osteonecrosis of jaw,16564996
2,2,22.0,Pulmonary mass,16564996
0,6,22.0,Infection,16565002
1,5,22.0,Sepsis,16565002
2,6,22.0,Amputation,16565002
3,6,22.0,Pneumonia bacterial,16565002
4,6,22.0,Acute kidney injury,16565002
0,1,22.0,Diarrhoea,16565038
1,6,22.0,Drug ineffective,16565038
2,6,22.0,Vomiting,16565038
3,1,22.0,Lip pain,16565038
4,1,22.0,Lip swelling,16565038
5,6,22.0,Nausea,16565038
6,6,22.0,Memory impairment,16565038
7,5,22.0,General physical health deterioration,16565038
8,6,22.0,Balance disorder,16565038
9,6,22.0,Hypersensitivity,16565038
10,2,22.0,Dry mouth,16565038
11,2,22.0,Metastases to central nervous system,16565038
0,,22.0,Death,16565065
0,6,22.0,Nausea,16565067
1,6,22.0,Dizziness,16565067
2,6,22.0,Metastases to central nervous system,16565067
3,6,22.0,Vomiting,16565067
0,1,22.0,Varices oesophageal,16565070
1,1,22.0,Diarrhoea,16565070
2,3,22.0,Hepatic enzyme increased,16565070
3,1,22.0,Faeces discoloured,16565070
4,1,22.0,Bile duct stone,16565070
5,1,22.0,Haematemesis,16565070
0,6,22.0,Asthenia,16565087
1,6,22.0,Decreased appetite,16565087
2,6,22.0,Liver injury,16565087
3,6,22.0,Melaena,16565087
0,1,22.1,Pancytopenia,16565104
0,,22.0,Death,16565127
0,,22.0,Disease progression,16565132
0,6,22.0,Recurrent cancer,16565355
1,6,22.0,Drug intolerance,16565355
0,1,22.0,Eczema,16565369
1,6,22.0,Malaise,16565369
2,1,22.0,Pyrexia,16565369
3,1,22.0,Perivascular dermatitis,16565369
4,6,22.0,Nausea,16565369
5,1,22.0,Urticaria,16565369
6,1,22.0,Rash,16565369
7,1,22.0,Rash erythematous,16565369
0,,22.0,Hospice care,16565380
0,2,22.0,Blood creatinine increased,16565382
1,2,22.0,Urine flow decreased,16565382
0,6,22.0,Hypoacusis,16565464
0,1,22.0,Thrombocytopenia,16565503
0,6,22.0,Ventricular hypokinesia,16565505
0,6,22.0,Vomiting,16565510
1,6,22.0,Diarrhoea,16565510
2,6,22.0,Alopecia,16565510
3,6,22.0,Cystitis,16565510
4,6,22.0,Insomnia,16565510
5,6,22.0,Nausea,16565510
0,2,22.0,Intestinal metastasis,16565516
1,2,22.0,Metastases to stomach,16565516
2,2,22.0,Intestinal stenosis,16565516
3,2,22.0,Metastases to lymph nodes,16565516
4,2,22.0,Metastases to liver,16565516
5,1,22.0,Neutropenia,16565516
6,2,22.0,Dyspepsia,16565516
7,2,22.0,Metastases to bladder,16565516
8,6,22.0,Haematotoxicity,16565516
9,2,22.0,Vomiting,16565516
10,2,22.0,Abdominal pain,16565516
11,2,22.0,Malignant neoplasm progression,16565516
0,2,22.1,Pruritus,16565535
1,3,22.1,Tachycardia,16565535
2,6,22.1,Skin sensitisation,16565535
3,6,22.1,Oral disorder,16565535
4,6,22.1,Red cell distribution width increased,16565535
5,6,22.1,Macrocytosis,16565535
6,6,22.1,Lymphocyte count decreased,16565535
7,6,22.1,Erythema,16565535
8,3,22.1,Hypersensitivity,16565535
9,2,22.1,Abdominal pain upper,16565535
10,6,22.1,Eating disorder,16565535
11,6,22.1,Confusional state,16565535
12,1,22.1,Abdominal discomfort,16565535
13,3,22.1,Headache,16565535
14,6,22.1,Hepatic enzyme abnormal,16565535
15,1,22.1,Pyrexia,16565535
16,6,22.1,Irritable bowel syndrome,16565535
17,2,22.1,Cystitis,16565535
18,6,22.1,Red blood cell count decreased,16565535
19,6,22.1,Neutrophil count decreased,16565535
20,1,22.1,Cystitis,16565535
21,6,22.1,Anxiety,16565535
22,1,22.1,Depressed mood,16565535
23,3,22.1,Nasopharyngitis,16565535
24,3,22.1,Asthenia,16565535
25,6,22.1,Nervousness,16565535
26,6,22.1,Anisocytosis,16565535
27,6,22.1,Decreased immune responsiveness,16565535
28,6,22.1,Gamma-glutamyltransferase increased,16565535
29,6,22.1,Alanine aminotransferase increased,16565535
30,6,22.1,Fatigue,16565535
31,6,22.1,Hepatic mass,16565535
32,6,22.1,Metastases to liver,16565535
33,6,22.1,Rash,16565535
34,3,22.1,Cough,16565535
35,6,22.1,Mean cell haemoglobin increased,16565535
36,6,22.1,White blood cell count decreased,16565535
37,6,22.1,Acne,16565535
38,6,22.1,Discomfort,16565535
39,6,22.1,Anaemia,16565535
40,6,22.1,Mean cell volume increased,16565535
41,6,22.1,Aspartate aminotransferase increased,16565535
42,6,22.1,Urinary tract infection,16565535
0,,22.0,Laboratory test abnormal,16565558
0,1,22.1,Diarrhoea,16565617
1,2,22.1,Fatigue,16565617
0,6,22.1,Off label use,16565654
1,6,22.1,Product use in unapproved indication,16565654
2,6,22.1,Drug effective for unapproved indication,16565654
0,6,22.0,Neoplasm progression,16565680
0,5,22.1,Cardiac failure,16565769
1,3,22.1,Dehydration,16565769
2,5,22.1,Pneumonia,16565769
3,1,22.1,Cardiac failure,16565769
4,1,22.1,Neutrophil count decreased,16565769
5,1,22.1,Neutrophil count decreased,16565769
0,1,22.0,Blood pressure increased,16565777
0,1,22.0,Hypertensive encephalopathy,16565814
0,3,22.0,Blood creatinine increased,16565824
1,6,22.0,Lymphocyte count decreased,16565824
2,1,22.0,Nucleated red cells,16565824
3,6,22.0,Red cell distribution width increased,16565824
4,6,22.0,Creatinine renal clearance decreased,16565824
5,6,22.0,Nausea,16565824
6,6,22.0,Blood phosphorus increased,16565824
7,6,22.0,Blood albumin decreased,16565824
8,1,22.0,Neutrophil count decreased,16565824
9,6,22.0,Blood urea increased,16565824
10,4,22.0,Rhabdomyolysis,16565824
11,6,22.0,Hyperkalaemia,16565824
12,6,22.0,Decreased appetite,16565824
13,6,22.0,Haematocrit decreased,16565824
14,1,22.0,White blood cell count decreased,16565824
15,6,22.0,Cellulitis,16565824
16,6,22.0,Anaemia,16565824
17,6,22.0,Aspartate aminotransferase increased,16565824
18,6,22.0,Haemoglobin decreased,16565824
19,6,22.0,Blood lactate dehydrogenase increased,16565824
20,3,22.0,Chronic kidney disease,16565824
21,6,22.0,Vomiting,16565824
22,6,22.0,Constipation,16565824
23,6,22.0,Fluid overload,16565824
24,6,22.0,Blood urea increased,16565824
25,6,22.0,Blood creatine phosphokinase increased,16565824
26,6,22.0,Glomerular filtration rate increased,16565824
27,6,22.0,Red blood cell count decreased,16565824
28,6,22.0,Alanine aminotransferase increased,16565824
29,6,22.0,Blood calcium increased,16565824
30,1,22.0,Mean cell volume abnormal,16565824
31,6,22.0,Platelet count decreased,16565824
32,1,22.0,Differential white blood cell count abnormal,16565824
33,6,22.0,Blood alkaline phosphatase increased,16565824
34,6,22.0,C-reactive protein increased,16565824
0,5,22.0,Death,16565835
0,6,22.0,Nasal disorder,16565838
1,6,22.0,Lower limb fracture,16565838
2,6,22.0,Tonsillar disorder,16565838
0,6,22.0,Colorectal cancer metastatic,16565857
1,6,22.0,Disease progression,16565857
0,6,22.1,Neoplasm progression,16565865
1,6,22.1,Intestinal obstruction,16565865
0,6,22.0,Fatigue,16565894
0,3,22.1,Hypoaesthesia,16565909
1,3,22.1,Peripheral swelling,16565909
0,6,22.0,Full blood count decreased,16565912
0,6,22.1,Bedridden,16565933
1,6,22.1,Speech disorder,16565933
2,6,22.1,Cough,16565933
0,6,22.0,Neoplasm progression,16565934
1,6,22.0,White blood cell count decreased,16565934
2,1,22.0,Neutropenia,16565934
0,6,22.0,Nausea,16565935
1,6,22.0,Neoplasm progression,16565935
2,3,22.0,Contusion,16565935
3,3,22.0,Increased tendency to bruise,16565935
4,6,22.0,Asthenia,16565935
5,6,22.0,Haemorrhage,16565935
6,6,22.0,Malaise,16565935
7,6,22.0,Blood disorder,16565935
0,2,22.0,Injection site erythema,16565938
1,2,22.0,Haemorrhage subcutaneous,16565938
2,2,22.0,Injection site mass,16565938
3,2,22.0,Injection site swelling,16565938
4,2,22.0,Injection site pain,16565938
0,6,22.0,Formication,16565940
1,6,22.0,Hydronephrosis,16565940
2,6,22.0,Cutaneous calcification,16565940
3,6,22.0,Prostate cancer,16565940
4,6,22.0,Hydroureter,16565940
5,6,22.0,Musculoskeletal stiffness,16565940
6,6,22.0,Asthenia,16565940
7,6,22.0,General physical health deterioration,16565940
8,6,22.0,Haemoglobin decreased,16565940
9,6,22.0,Dyspepsia,16565940
0,1,22.0,Urticaria,16566023
1,1,22.0,Rash pruritic,16566023
2,6,22.0,Drug hypersensitivity,16566023
0,3,22.0,Granulocytopenia,16566056
0,1,22.0,Cholangitis sclerosing,16566112
0,1,22.0,Sinusitis,16566271
1,3,22.0,Hair growth abnormal,16566271
2,1,22.0,Product dose omission,16566271
3,6,22.0,Platelet count decreased,16566271
4,3,22.0,Neuropathy peripheral,16566271
0,2,22.0,Periarthritis,16566332
0,2,22.0,Pneumonia,16566489
1,3,22.0,Hyperbilirubinaemia,16566489
0,6,22.0,Accident,16566494
1,6,22.0,Product dose omission,16566494
0,1,22.0,Urinary tract infection,16566495
0,1,22.0,Chest discomfort,16566498
0,6,22.0,Fatigue,16566500
1,6,22.0,White blood cell count decreased,16566500
2,6,22.0,Alopecia,16566500
0,6,22.0,Product use in unapproved indication,16566604
1,2,22.0,Liver injury,16566604
2,6,22.0,Off label use,16566604
0,5,22.0,Death,16566654
0,5,22.0,Death,16566667
0,2,22.0,Peripheral artery thrombosis,16566677
1,6,22.0,Neoplasm progression,16566677
0,6,22.0,Rash,16566686
1,6,22.0,Weight decreased,16566686
2,6,22.0,Bone marrow failure,16566686
0,1,22.1,Diarrhoea infectious,16566693
1,1,22.1,Pyrexia,16566693
0,1,22.1,Dyschromatopsia,16566696
1,2,22.1,Fatigue,16566696
2,3,22.1,Photophobia,16566696
3,6,22.1,Bone marrow failure,16566696
4,2,22.1,Weight decreased,16566696
5,1,22.1,Photosensitivity reaction,16566696
6,1,22.1,Anaemia,16566696
7,1,22.1,White blood cell count decreased,16566696
0,5,22.0,Death,16566708
0,6,22.0,Metastases to bone,16566735
1,3,22.0,Lymphangiosis carcinomatosa,16566735
2,1,22.0,Pulmonary toxicity,16566735
0,2,22.0,Thrombocytopenia,16566762
1,2,22.0,Rash,16566762
2,2,22.0,Polymyalgia rheumatica,16566762
3,2,22.0,Anaemia,16566762
4,2,22.0,Diarrhoea,16566762
0,2,22.0,Pneumonitis,16566772
1,2,22.0,Hypoxia,16566772
0,6,22.0,Skin reaction,16566777
1,6,22.0,Neutropenia,16566777
2,6,22.0,Thrombocytopenia,16566777
3,6,22.0,Stomatitis,16566777
4,6,22.0,Diarrhoea,16566777
5,6,22.0,Perineal disorder,16566777
0,2,22.0,Malignant neoplasm progression,16566827
1,6,22.0,Neurotoxicity,16566827
2,1,22.0,Anaemia,16566827
3,2,22.0,Cholangiocarcinoma,16566827
4,6,22.0,Neutropenia,16566827
5,6,22.0,Renal failure,16566827
6,1,22.0,Thrombocytopenia,16566827
7,1,22.0,Haematotoxicity,16566827
8,1,22.0,Paraesthesia,16566827
9,6,22.0,Product use in unapproved indication,16566827
10,6,22.0,Oral candidiasis,16566827
0,5,22.0,Cardiac failure,16566829
0,6,22.1,Off label use,16566838
1,3,22.1,Lung adenocarcinoma,16566838
2,1,22.1,Renal impairment,16566838
0,2,22.0,Pneumonitis,16566855
0,6,22.0,Metastases to central nervous system,16566883
0,6,22.0,Radiation pneumonitis,16566894
0,1,22.0,Nausea,16566940
1,1,22.0,Fatigue,16566940
2,1,22.0,Decreased appetite,16566940
3,6,22.0,Dysphagia,16566940
4,1,22.0,Weight decreased,16566940
5,1,22.0,Dysgeusia,16566940
0,1,22.1,Rash,16566955
1,1,22.1,Pruritus,16566955
2,1,22.1,Bacille Calmette-Guerin scar reactivation,16566955
0,1,22.0,Hypovolaemic shock,16567034
1,1,22.0,Diarrhoea,16567034
2,1,22.0,Renal failure,16567034
0,3,22.1,Anaemia,16567097
1,3,22.1,Hyperbilirubinaemia,16567097
0,5,22.0,Ovarian cancer recurrent,16567183
1,5,22.0,Metastases to meninges,16567183
2,6,22.0,General physical health deterioration,16567183
0,3,22.0,Gait disturbance,16567261
1,3,22.0,Pain in extremity,16567261
2,6,22.0,Metastasis,16567261
3,3,22.0,Asthenia,16567261
4,6,22.0,Blood creatinine increased,16567261
5,6,22.0,Haemoglobin decreased,16567261
0,1,22.0,Pneumocystis jirovecii pneumonia,16567316
1,2,22.0,Pancytopenia,16567316
0,5,22.0,Death,16567400
0,1,22.0,Neutropenia,16567438
0,3,22.0,Throat irritation,16567544
1,3,22.0,Pain in extremity,16567544
2,6,22.0,Pulmonary pain,16567544
3,6,22.0,Fall,16567544
4,3,22.0,Sciatica,16567544
5,3,22.0,Fatigue,16567544
6,3,22.0,Asthenia,16567544
7,6,22.0,Diarrhoea,16567544
8,6,22.0,Pain in extremity,16567544
9,6,22.0,Head injury,16567544
10,3,22.0,Back pain,16567544
11,6,22.0,Loss of consciousness,16567544
12,3,22.0,Musculoskeletal pain,16567544
0,1,22.0,Radiation pneumonitis,16567553
1,1,22.0,Pruritus,16567553
0,6,22.0,Neoplasm progression,16567567
0,1,22.0,Crying,16567701
1,1,22.0,Depression,16567701
0,1,22.0,Malignant neoplasm progression,16567704
1,6,22.0,General physical health deterioration,16567704
2,6,22.0,Weight decreased,16567704
0,6,22.0,Hepatotoxicity,16567708
1,6,22.0,Subcutaneous emphysema,16567708
2,6,22.0,Drug ineffective,16567708
3,6,22.0,Toxicity to various agents,16567708
4,6,22.0,Nausea,16567708
5,6,22.0,Product use in unapproved indication,16567708
6,6,22.0,Off label use,16567708
7,6,22.0,Incorrect route of product administration,16567708
8,6,22.0,Vomiting,16567708
9,6,22.0,Subileus,16567708
10,6,22.0,Abdominal pain,16567708
11,6,22.0,Hypoalbuminaemia,16567708
0,1,22.0,Thrombocytopenia,16567727
1,1,22.0,Thrombocytopenia,16567727
0,1,22.1,Hepatic function abnormal,16567758
0,1,22.0,Haemophagocytic lymphohistiocytosis,16567786
0,6,22.0,Infusion related reaction,16567863
1,6,22.0,Extrasystoles,16567863
2,6,22.0,Malaise,16567863
3,6,22.0,Hypotension,16567863
0,6,22.0,Brain oedema,16567865
0,1,22.0,Constipation,16567866
1,1,22.0,Dyspepsia,16567866
2,1,22.0,Diarrhoea,16567866
3,3,22.0,Neurotoxicity,16567866
4,1,22.0,Pain,16567866
5,3,22.0,Rash pustular,16567866
6,1,22.0,Rash,16567866
7,1,22.0,Aphthous ulcer,16567866
8,1,22.0,Pollakiuria,16567866
9,6,22.0,Pyrexia,16567866
10,1,22.0,Conjunctivitis,16567866
11,1,22.0,Nausea,16567866
12,1,22.0,Stomatitis,16567866
13,1,22.0,Asthenia,16567866
14,1,22.0,Haemorrhoids,16567866
0,6,22.0,Orchitis,16567868
